Stock IdeasStrong Buy Stocks

Strong Buy Stocks from Top Wall Street Analysts

Latest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen

Citigroup's Joanne Wuensch raised their price target on Minimed Group (NASDAQ: MMED) by 13% from $23 to $26 on 2026/09/02. The analyst maintained their Strong Buy rating on the stock.

MiniMed Group reported its Q1 2027 earnings.

Raising their price target, Wuensch cited the quarter's better-than-expected results.

Earnings Report

For Q1 2027, MiniMed Group reported:

• EPS of n/a.
• Revenue of $843, up 16.6% Y/Y.

For FY 2027, management guided:

• 10.5% Y/Y organic revenue growth, up from the prior 10%.

CEO Que Dallara commented: "MiniMed delivered an excellent start to our fiscal year, with accelerating U.S. growth, continued double-digit international growth, and strong execution across our innovation pipeline.

"The U.S. launch of MiniMed Flex™ is doing exactly what we designed it to do: bringing new patients into the MiniMed ecosystem, driving competitive conversions, and generating significant new account growth.

"As our ecosystem continues to come together, we are well positioned to accelerate growth, strengthen our leadership in automated insulin delivery, and create long-term shareholder value."